Sir Michael Craig-Cooper (Temple 54)

Michael writes, “Currently I am advising two Australian companies, TurbineMachineGenes Pty. Ltd. (TMG), which has evolved a revolutionary engine productive analytics software, and Diabetes Neuromathix Pty. Ltd. (DNx), which addresses diabetes personalised insulin dosage strategies for those with medical histories of therapeutic failures, with a view to moving most of their global operations to London. Earlier this year I was appointed Deputy Chairman of International Trust Arbitration Organisation (ITAO), which specialises in the resolution of Common Law disputes. Although the body is located in Liechtenstein, its focus is on the leading Commonwealth fiduciary jurisdictions with proceedings conducted in English.”